Dr. Jennifer Nelson explains how Kaiser Permanente scientists are helping the CDC and FDA keep an eye out for rare adverse events.
Susan Brandzel cues up our tunes as we look ahead to better days in the new year.
The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.